Home >Technologies Available >Technologies available for licensing

QCOVID® – A validated individual risk prediction score to identify patients at high risk of severe COVID-19 outcomes

Image from Licence Details: QCOVID® – A validated individual risk prediction score to identify patients at high risk of severe COVID-19 outcomes

Applications: Clinical decision-making, clinical trial patient stratification, market access and reimbursement

QCovid® was used by the NHS in 2021 to identify patients in England at high risk of severe COVID-19 outcomes, adding an additional 1.7 million people to the national shielded patient list and informing vaccine prioritisation.

Features Benefits
  • Robust tool, shows excellent performance in identifying patients most at risk of severe COVID-19
  • QCovid v1-3 has been independently externally validated in England, Wales and Scotland
  • Calculates cumulative absolute risk associated with multiple co-morbidities, age, prior infection, and vaccination status
  • Latest version (QCovid4) considers previous infection and vaccination status
  • Provides a combined individualised risk prediction measure which can be used to better inform clinical decision-making
  • Based on very large population data sources that have been used to develop other, widely-used risk prediction tools
  • More accurately identifies patients at the highest absolute risk levels, so can be used to target COVID-19 therapies, and clinical trial patient selection
Request more information
about this technology

Back to Technologies Available

Sparks Background Image

Ready to get in touch?

Contact Us
Sparks Background Image
© Oxford University Innovation